Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOLIFE SOLUTIONS INC Director's Dealing 2020

Mar 28, 2020

32106_dirs_2020-03-27_eb8f8229-2a30-44f7-9c8a-ed285cc0ef99.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2020-03-25

Reporting Person: Mathers James (Chief Revenue Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-03-25 Common Stock A 3101 Acquired 19977 Direct

Footnotes

F1: The restricted stock pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests in full on September 25, 2020. This restricted stock was granted to the reporting person in lieu of such reporting person's 2019 cash performance bonus.